Summary & Overview
CPT 38760: Superficial Inguinofemoral Lymph Node Excision
CPT code 38760 represents the surgical excision of superficial inguinal and femoral (inguinofemoral) lymph nodes, a procedure commonly used in oncologic management of cancers affecting the lower abdomen, pelvis, or lower extremity. Nationally, this code is important for capturing surgical care related to regional lymphadenectomy, informing surgical quality measurement, reimbursement, and care coordination across inpatient and outpatient surgical settings. Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of clinical context and the typical settings for this procedure, plus benchmarking insights and policy-relevant considerations. The publication outlines utilization patterns, common coding considerations, and comparisons across major payers where available. It also summarizes relevant documentation elements that typically support billing for a superficial inguinofemoral lymph node excision and highlights areas where payer policy or prior authorization may influence coding and payment. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 38760 describes the surgical excision of superficial inguinal and femoral lymph nodes. The procedure involves removal of lymph nodes located in the groin and upper thigh regions; it does not include excision of lymph nodes situated deep beneath muscle layers. This operation is commonly performed for oncologic indications involving malignancy of the lower abdomen, pelvis, or lower extremity when removal of superficial inguinofemoral lymph nodes is indicated.
-
Service type: Surgical lymph node excision (superficial inguinofemoral lymphadenectomy)
-
Typical site of service: Operating room or surgical suite, performed at the inguinal/groin and proximal thigh (femoral) region
Clinical & Coding Specifications
Clinical Context
A 62-year-old female with a recently diagnosed squamous cell carcinoma of the vulva is scheduled for surgical management that includes excision of the primary tumor and regional lymph node assessment. The surgical team plans an inguinofemoral lymphadenectomy to remove superficial inguinal and femoral lymph nodes for staging and local disease control. The patient presents preoperatively to the outpatient surgical clinic for informed consent, history and physical, and perioperative planning. On the day of surgery, general anesthesia is induced in an ambulatory surgical center or hospital operating room. The surgeon makes an incision in the groin crease, dissects through subcutaneous tissues to identify and excise superficial inguinofemoral lymph nodes while preserving deep femoral and pelvic nodes. Specimens are sent for frozen section or permanent pathology. Postoperative care includes wound management, pain control, DVT prophylaxis, and follow-up for pathology results and adjuvant therapy planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or routine postoperative care | When reporting the global surgical service during the postoperative period for the primary surgeon. |
22 | Increased procedural services |